We found that intratracheal implantation of hUC-MSCs increased the survival rates and significantly attenuated severe burn-induced ALI via inhibiting pulmonary inflammation, and the therapeutic effects of hUC-MSCs were strongly reduced when the expression of TSG-6 was inhibited via RNA interference. This evidence concerns the gene TNFAIP6 and inflammation.